An Expert Opinion on the Management of Type 2 Diabetes Mellitus in Children and Adolescents

被引:1
|
作者
Rajput, Rajesh [1 ]
Jha, Sujeet [2 ]
Panda, Jayanta Kumar [3 ]
Subrahmanyam, Appalavenkata Kandregula [4 ]
Das, Sambit [5 ,6 ]
机构
[1] Pandit Bhagwat Dayal Sharma Postgrad Inst Med Sci, Dept Endocrinol, Med Rd, Rohtak 124001, Haryana, India
[2] Max Super Specialty Hosp, Inst Endocrinol Diabet & Metab, South Block,2,Press Enclave Rd, New Delhi 110017, India
[3] SLN Med Coll, Metab & Crit Care Med, Dept Med, Koraput 764020, Odisha, India
[4] Andhra Med Coll, King George Hosp, Vishakhapatnam, Andhra Pradesh, India
[5] Apollo Hosp, ACODE & Sugar Clin, Bhubaneswar, Odisha, India
[6] Hitech Med Coll & Hosp, Hitech Hosp Rd, Bhubaneswar 751025, Odisha, India
关键词
Adolescents; children; India; insulin; type 2 diabetes mellitus; AMERICAN YOUTH PREVALENCE; CLINICAL CHARACTERISTICS; CARE; OBESITY; SEARCH; ADULTS; YOUNG; LIFE; RETINOPATHY; CHILDHOOD;
D O I
10.4103/jod.jod_71_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus (T2DM) is an emerging epidemic among children and adolescents. There is a lack of comprehensive guidance to clinicians for the management of T2DM in this patient population. An expert panel of diabetes specialists from India reviewed the available literature, discussed, and proposed six recommendations on the identification of risk factors leading to the development of T2DM, diagnosis of T2DM, and non-pharmacological and pharmacological management of T2DM in children and adolescents. According to these recommendations, the most common risk factors leading to T2DM in children are obesity, metabolic syndrome, insulin resistance, family history, puberty, and genetic abnormalities. Diagnosis of T2DM in children and adolescents should be based on plasma glucose levels, with recommendation to test glycated hemoglobin levels quarterly. Lifestyle modifications may help in improving outcomes. Among pharmacological treatments, insulin and metformin are currently the approved first-line therapies and liraglutide is recommended if glycemic targets are no longer met with metformin or insulins. Early identification of risk factors, along with early diagnosis and initiation of insulin therapy with lifestyle modifications, may help in delaying the chronic complications associated with T2DM in children and adolescents.
引用
收藏
页码:424 / 433
页数:10
相关论文
共 50 条
  • [31] Type 2 diabetes mellitus in Danish children and adolescents in 2014
    Oester, Ida Margrethe Bach
    Kloppenborg, Julie Tonsgaard
    Olsen, Birthe Susanne
    Johannesen, Jesper
    PEDIATRIC DIABETES, 2016, 17 (05) : 368 - 373
  • [32] The global spread of type 2 diabetes mellitus in children and adolescents
    Pinhas-Hamiel, O
    Zeitler, P
    JOURNAL OF PEDIATRICS, 2005, 146 (05): : 693 - 700
  • [33] Prevention of obesity and type 2 diabetes mellitus in children and adolescents
    Reinehr, T.
    DIABETOLOGIE UND STOFFWECHSEL, 2007, 2 (06) : 359 - 361
  • [34] Metabolic disorders in children and adolescents with type 2 diabetes mellitus
    Huang, Chi Yu
    Lee, Yann Jinn
    Li, Hsin Jung
    Chen, Ming Ren
    Lee, Hung Change
    Lo, Fu Sung
    HORMONE RESEARCH, 2006, 65 : 52 - 52
  • [35] Cardiovascular Risk in Children and Adolescents with Type 2 Diabetes Mellitus
    Prendergast, Christopher
    Gidding, Samuel S.
    CURRENT DIABETES REPORTS, 2014, 14 (02)
  • [36] Cardiovascular Risk in Children and Adolescents with Type 2 Diabetes Mellitus
    Christopher Prendergast
    Samuel S. Gidding
    Current Diabetes Reports, 2014, 14
  • [37] Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents
    Copeland, Kenneth C.
    Silverstein, Janet
    Moore, Kelly R.
    Prazar, Greg E.
    Raymer, Terry
    Shiffman, Richard N.
    Springer, Shelley C.
    Thaker, Vidhu V.
    Anderson, Meaghan
    Spann, Stephen J.
    Flinn, Susan K.
    PEDIATRICS, 2013, 131 (02) : 364 - 382
  • [38] Multidisciplinary management of type 2 diabetes in children and adolescents
    Bowen, Michael E.
    Rothman, Russell L.
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2010, 3 : 113 - 124
  • [39] Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus
    Magge S.N.
    Current Cardiovascular Risk Reports, 2012, 6 (6) : 591 - 600
  • [40] MOBILE APPLICATION "EUGLYCA'' IN MANAGEMENT OF DIABETES MELLITUS TYPE 1 IN CHILDREN AND ADOLESCENTS
    Chatzakis, C.
    Floros, D.
    Tsiroukidou, K.
    Vamvakis, A.
    Kosta, K.
    Tsanakas, I.
    Papagianni, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A44 - A44